Why Did The Clovis (CLVS) Stock Rise By 15% In Pre-Market Session?

Following an insolvency filing by the biopharmaceutical company on the previous day Wednesday, Clovis Oncology Inc. (NASD: CLVS) has increased 15.02% to $0.1532 in pre-market trading hours. Which filing has CLVS made? On Monday, Clovis (CLVS) disclosed that it, along with a few of its subsidiaries (the “Debtors” collectively), had voluntarily filed for Chapter 11 bankruptcy in […]